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132 integrins are required for neutrophil degranulation induced
by hemodialysis membranes
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I2 integrins are required for neutrophil degranulation induced by
hemodialysis membranes. An untoward consequence of hemodialysis is
degranulation of peripheral blood neutrophils. The mechanisms that
mediate this process, however, have not been conclusively identified.
In the present study, the participation of complement activation and 132
integrins (CD1 I/CD 18) in hemodialysis-induced neutrophil degranula-
tion was investigated. Incubation of neutrophils with cuprophan mem-
brane stimulated the release of very small amounts of the cytoplasmic
granular protein, elastase. This release was markedly enhanced by the
addition of plasma. Inactivation of complement reduced degranulation
by --60%, but the contribution of anaphylatoxins C3a and C5a to the
degranulation process was modest. Treatment of plasma with EDTA
completely abolished neutrophil degranulation in the presence of cu-
prophan membrane. Further, when incubated with plasma and Cu-
prophan membrane, neutrophils that are deficient in /32 integrins re-
leased only 10% as much elastase as normal cells. Together, these
observations strongly suggest that one or more members of the /2
integrin family of receptors is essential for cuprophan membrane-
induced neutrophil degranulation and that both complement-related and
noncomplement-related factors serve as receptor ligands.
During hemodialysis, a variety of biologically active sub-
stances that have pathophysiological consequences are gener-
ated in the peripheral blood. These substances include prom-
flammatory fragments of complement proteins that are
generated as a result of activation of the alternative pathway of
complement (APC) [1—4]. The cellular response to acute inflam-
mation is mediated largely by neutrophils because they have
evolved a spectrum of functional characteristics that are acti-
vated by elements of the humoral immune system. As a
principal mediator of humoral immunity, the complement sys-
tem orchestrates many neutrophil functions. For example, C5a
mediates chemotaxis [51, and binding of activation (C3b) and
degradation (iC3b) products of C3 targets foreign substances for
recognition by neutrophils through interactions with specific
receptors (that is, complement receptor type 1, CR!; and
complement receptor type 3, CR3, respectively) on the cell
surface [6].
Hemodialysis has been shown to affect a variety of neutrophil
functions. The neutropenia of hemodialysis has been exten-
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sively investigated, and compelling evidence indicates that the
phenomenon is a consequence of C5a-induced neutrophil ag-
gregation [7—9]. Other neutrophil dysfunctions associated with
dialysis include degranulation [10—17], diminished oxidative
metabolism [18], abnormal chemotaxis and aggregation [19],
and impairment of phagocytic function [20]. Together, this
constellation of findings suggest that neutrophils have under-
gone activation induced by products of immune reactions
during dialysis. Indirect evidence suggests that complement
related proteins participate in the induction of this dysfunc-
tional state because the severity of the disturbance correlates
with the capacity of the dialysis membrane to support comple-
ment activation [3, 20].
Stored in the primary (azurophilic) granules of neutrophils
are proteins that possess proteolytic and antimicrobial proper-
ties. Release of these intracellular constituents (degranulation)
in response to specific inflammatory stimuli is an essential
element of host defense [21]. Neutrophil degranulation during
hemodialysis has been reported [10—17], and evidence suggests
that the proteolytic enzymes that are released into plasma as a
result of this process contribute to the catabolic state that is
observed during clinical hemodialysis [11, 12]. More recently,
some investigators have postulated that neutrophil elastase
release participates in the pathogenesis of carpal tunnel syn-
drome that is commonly seen in the dialysis patients [17].
Clinical studies show that hemodialysis using different types of
membranes is associated with different degrees of degranulation
[13—16]. Interestingly, cuprophan, which is associated with
more elastase release than polyacrylonitrile [13], also induces
more protein catabolism during sham hemodialysis in humans
[22].
The mechanisms that induce dialysis-associated neutrophil
degranulation have not been elucidated. Horl and colleagues
found that plasma concentrations of the granular proteins did
not correlate closely with the degree of complement activation
as indicated by plasma C3a(desArg) levels [13—16], and those
investigators have hypothesized that other factors contribute to
the degranulation process. Shearing of the cells at the blood-
dialysis membrane interphase has been proposed as one possi-
ble mechanism, but convincing data to support this hypothesis
are lacking.
The studies reported herein were designed to analyze the
effects of complement activation by hemodialysis membranes
on neutrophil degranulation. Cuprophan membranes were used
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because their interactions with complement have been exten-
sively characterized [2, 3, 23, 24]. As a marker of neutrophil
activation, release of elastase (a constituent of primary gran-
ules) was quantitated. Our experiments have shown that de-
granulation is partially dependent on complement activation
and partially dependent on heat-stable plasma factors that do
not require complement activation but are dependent on cal-
cium. These complement dependent and complement indepen-
dent factors induce degranulation through binding to one or
more members of the /32 integrin family of receptors.
Methods
Buffers and reagents
The following buffers and reagents were used: PBS, 10 mri
sodium phosphate, pH 7.4 containing 145 mM NaC1; PBS-
Tween, 0.5 ml of Tween-20 (Sigma Chemical Co., St. Louis,
Missouri, USA) per liter of PBS; HBSS/A, Hank's balanced
saline solution containing 0.5% (wt/vol) human serum albumin
(Albuminar®, Armour Pharmaceutical, Kankakee, Illinois,
USA); bovine serum albumin (BSA, Sigma Chemical Co.);
carbonate buffer, 0.2 M Na2CO3 and 0.25 M NaHCO3; disodium
ethylenediamine tetraacetate (EDTA, Sigma Chemical Co.);
disodium ethyleneglycol tetraacetate (EGTA, Sigma Chemical
Co.).
Plasma preparation and neutrophil isolation
Approximately 100 ml of blood (anticoagulated with 2 units of
heparin/mi) were obtained from healthy volunteers who had not
taken medication within 72 hours of the phlebotomy. Plasma
was immediately separated by centrifugation. For some exper-
iments, the separated plasma was immediately mixed with
either EDTA (10 m final concentration) or Mg-EGTA (2.5 mM
MgCl2 and 8 m EGTA final concentration). After incubation at
37°C for five minutes to allow chelation of metals, the plasma
was kept at 4°C prior to use in experiments. Other aliquots of
plasma were heated at 56°C for 30 minutes immediately after
separation from whole blood. This reagent is called heat-
inactivated plasma. In some instances, heat-inactivated plasma
was also treated with Mg-EGTA as described above.
Additional heparin (5.5 u/mi) was added to the portion of the
blood from which the cells were isolated. Neutrophils were
isolated by dextran sedimentation, hypotonic lysis of erythro-
cytes, and density gradient centrifugation (Ficoll-Paque®, Phar-
macia LKB Biotechnology, Piscataway, New Jersey, USA) as
previously described [25] and were resuspended in HBSS/A.
The cell preparations contained > 95% granulocytes as deter-
mined by microscopic examination of slides stained with
Wright's reagent, and the cells were 99% viable as determined
by Trypan blue exclusion.
Neutrophils from a number of different donors were used in
these studies. On a given day, however, the same donor's cells
were used in all parallel experiments. The only exception was
the experiments in which normal and CD18 deficient cells were
compared (as described below).
Dialyzer membrane
Cuprophan hollow fibers were obtained from commercially
available dialyzers (CFl2ll, Baxter-Travenol, Deerfield, Illi-
nois, USA). They were cut into fragments of -1 cm in length.
Based on the nominal surface area of the blood compartment of
a whole dialyzer (0.8 M2), the wall thickness of the fibers (11
sM), the number of the fibers in the dialyzer (6,100), and the
measured weight of the fibers, the surface area-to-weight ratio
of the fibers was estimated to be 0.95 cm2/mg. This calculation
takes into account both the inner and outer surfaces of the
hollow fibers. Unless specified otherwise, 14 mg of fibers
(—13.3 cm2 in total surface area) were used in each of the
experimental tubes described below.
ELISA for elastase
Elastase antigen was measured using an enzyme-linked im-
munosorbent assay (ELISA) developed in our laboratory using
standard Sandwich ELISA methodology [26] and commercially
available protein and antibodies. Rabbit anti-human elastase
IgG (Biodesign International, Kennebunkport, Maine, USA)
that had been conjugated with horseradish peroxidase (Sigma
Chemical Co.) according to the method of Nakane and Kawaoi
[27] was used as the detector antibody. The wells of a 96-well
microtiter plate (Nunc-Immuno Plate, A/S Nunc, Roskilde,
Denmark) were incubated at 37°C with 100 jsl of carbonate
buffer containing 20 ,sg/mi sheep anti-human elastase IgG (ICN
ImmunoBiologicals, Lisle, Illinois, USA). After two hours, the
wells were washed with PBS-Tween, and 100 d of HBSS
containing 1% BSA and either human elastase standards
(Biodesign International) or a dilution of the test sample were
added to the antibody-coated wells. After 90 minutes of incu-
bation at 37°C, the wells were again washed with PBS-Tween.
Next, 100 d of peroxidase conjugated anti-elastase (diluted
1:100 with PBS containing 1% BSA) were added to the wells,
and the incubation was continued at 37°C for 90 minutes. After
washing with PBS-Tween, the chromogenic substrate o-phe-
nylenediamine (Sigma Chemical Co.) was added to the wells,
and the A492 was measured subsequently by using a Titertek
Multiskan MCC spectrophotometer (Flow Laboratories, Inc.,
Santa Barbara, California, USA). The standard curve generated
by this method was linear between 2 and 100 ng/ml of elastase
suspended in either HBSS or diluted plasma that had been
immunochemically depleted of elastase.
Direct effect of cuprophan membrane on neutrophil
degranulation in the absence of plasma
An aliquot of 750 pi of HBSS/A containing 1 x 106 neutro-
phils was incubated in a 1.5 ml polypropylene tube (Life
Science products, Denver, Colorado, USA) at 37°C in the
presence or absence of 14 mg of cuprophan hollow fibers. After
two hours, the suspension was separated from the fibers by
using a Pasteur pipette. The cells in the suspension were
sedimented by centrifugation, and a 500 jsl aliquot of the
supernate was removed for use in the elastase assay. Fluid
phase elastase levels are accurate indicators of elastase release
from neutrophils in these experiments since pilot experiments
have demonstrated that there was no decrease in fluid phase
elastase concentration when purified elastase was incubated for
two hours with cuprophan fibers in a polypropylene tube in the
absence of cells (that is, there was no significant adsorption of
elastase to either the test tube surface or to the dialysis
membrane).
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Effect of normal human plasma (NHP) on neutrophil
degranulation in the presence or absence of cuprophan
membrane and effect of cuprophan-activated plasma
NHP (375 p1) and cuprophan fibers (14 mg) were incubated at
37°C with 375 p1 of HBSS/A containing 1 x 106 neutrophils. At
timed intervals between 15 minutes and four hours, the super-
nate was removed for elastase determination as described
above. These experiments showed that elastase release in-
creased in a linear fashion during the first hour. A plateau phase
was observed after one hour and no significant increase was
observed between one and four hours. Accordingly, subsequent
experiments were performed using a two-hour incubation pe-
riod.
In separate experiments, NHP was incubated at 37°C with
cuprophan a?the same ratio as described above (375 p1 of NHP
to 14 mg of cuprophan membrane) but cells were omitted. After
two hours, the supernate was recovered and 375 p1 of the
cuprophan-activated plasma were incubated with 375 1d of
HBSS/A containing 1 x 106 neutrophils. After two hours, the
supernate was assayed for elastase. Neutrophils incubated with
either NHP alone or HBSS/A alone served as controls.
Effect of heat treatment or metal chelation on plasma-
induced neutrophil degranulation in the presence of
cuprophan
Neutrophils (1 x 106 suspended in 375 p1 of HBSS/A) were
incubated in the presence of 14 mg of cuprophan fibers and 375
p1 of one of the following reagents: (i) heat-inactivated plasma;
(ii) EDTA-treated plasma; (iii) Mg-EGTA-treated plasma; (iv)
Mg-EGTA-treated, heat-inactivated plasma. Cells incubated
with NHP or buffer in the presence of cuprophan fibers served
as controls. After incubation, the supernates were assayed for
elastase. To determine if extracellular divalent cations are
required for degranulation induced by other mechanisms, 2.5 X
106 neutrophils were stimulated with 0.5 g/m1 (final concentra-
tion) of phorbol myristate acetate (PMA, Sigma Chemical Co.)
and PBS or PBS containing 10 mM EDTA for 45 minutes. The
supernate was subsequently assayed for elastase.
Preparation of plasma depleted of complement C3 or C5
Plasma depleted of either C3 or CS was prepared from NHP
using immunoaffinity chromatography as previously described
[28]. In brief, for C3-depleted plasma, polyclonal goat anti-
human C3 IgG (Organon Teknika-Cappel, Malvern, Pennsylva-
nia, USA) was conjugated to CNBr-activated Sepharose 4B
(Pharmacia) and treated with pepsin in order to generate F(ab')2
fragments according to a previously described protocol [29].
NHP was applied to the column containing this affinity adsor-
bent, and the A280 of the effluent (diluted 1:100) from the
column was measured. Fractions were pooled and diluted with
PBS such that the total protein concentration in the pooled
plasma was equal to 75% of that of NHP.
Depletion of C3 was confirmed by a hemolytic assay as
previously described [30]. In addition, the capacity of some
plasma pools to generate C3a was examined by incubating 375
p1 of the plasma with 375 p1 of HBSS/A and 14 mg of cuprophan
fibers at 37°C for two hours. The supernate was then assayed
for C3a(desArg) using a commercial kit (Amersham Corp., Ar-
lington Heights, Illinois, USA). The results showed that no C3a
was generated during the incubation (C3a(desArg) levels were 145
4 ng/ml and 164 18 nglml before and after incubation,
respectively; N = 4, P> 0.05). In contrast, incubation of NHP
(diluted to 75% with PBS) with cuprophan fibers under the same
conditions resulted in substantial generation of C3a as indicated
below. The effect of C3 depletion on C5a generation was also
tested. CSa(desA) was measured by RIA (Amersham). In the
absence of C3, CS activation is not expected to occur.
CSa(desA) concentrations were unaffected by incubation of
C3-depleted plasma with cuprophan membranes (35 3 nglml
and 39 I ng/ml before and after incubation, respectively; N =
4, P > 0.05). These data indicate that C3 depletion in the plasma
was complete. The C3-depleted plasma was frozen at —70°C
and used in experiments within seven days of preparation. An
aliquot of NHP from the same donor was also frozen for
comparison in the degranulation experiments described below.
As a control, human serum albumin (Albuminar8, Armour
Pharmaceutical) diluted to 4 gldl with PBS was passed through
the anti-C3 column using the same conditions as those used to
prepare the C3-depleted plasma.
CS-depleted plasma was prepared in a manner similar to that
described for C3-depletion except that polyclonal goat anti-
human CS IgG (Atlantic Antibodies, Scarborough, Maine,
USA) was used to prepare the immunoadsorbent. CS depletion
was confirmed by hemolytic assay. In addition, some CS-
depleted plasma pools were assayed for C5a generation follow-
ing incubation with cuprophan membrane as described above
for C3-depleted plasma, except that the RIA for CSa(desArg) was
used. CSa(desArg) concentrations were 23 2 ng/ml and 20 4
ng/ml before and after incubation with cuprophan, respectively
(N = 4,P > 0.05). As described below, incubation of NHP with
cuprophan membrane under the same conditions resulted in
substantial CSa generation.
Isolation of complement C3 and C5
C3 and CS were isolated from normal human serum by
published procedures [28]. The purity of the isolated proteins
was confirmed by SDS-PAGE analyses. The functional activity
of the proteins was confirmed in hemolytic assays [30].
Effect of C3 depletion on plasma-induced neutrophil
degranulation
Neutrophils (1 x 106) contained in HBSS/A and 14 mg of
cuprophan hollow fibers were incubated at 37°C with one of the
following reagents: (i) 375 p1 of NHP (diluted to 75% with PBS);
(ii) 375 1.d of C3-depleted plasma; (iii) 375 p1 of C3-depleted
plasma reconstituted with 420 sg of C3 (equivalent to plasma
C3 concentration of 1.2 mg/ml); (iv) 375 p1 of HBSS/A. For
each experiment on a given day, NHP and C3-depleted plasma
from the same blood donor were used. An equal volume of PBS
was added to the tubes that did not contain purified C3. The
total incubation volume remained constant at 750 p1. In sepa-
rate experiments, 1 x 106 neutrophils suspended in 375 p1 of
HBSS/A and 14 mg of cuprophan fibers were incubated with 375
p1 of either NHP or human serum albumin that had been passed
through the anti-C3 column. After two hours, the supernate was
removed and assayed for elastase.
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Effect of C5 depletion on plasma induced neutrophil
degranulation
These experiments were performed in a manner similar to
that described above for C3-depleted plasma except that CS-
depleted plasma and purified CS (70 g, equivalent to plasma C5
concentration of 200 igIml) were used instead of C3-depleted
plasma and purified C3. For each experiment on a given day,
NHP and CS-depleted plasma from the same blood donor were
used.
Generation of C3a and C5a in plasma induced by contact
with cuprophan
An aliquot of 375 jsl of NHP (diluted to 75% with PBS) was
incubated with 375 d of HBSS/A containing either 14 mg of
cuprophan fibers or 14 mg of cuprophan fibers and 3.75 x 106
neutrophils. After 120 minutes, 25 sl of 0.2 M EDTA were
added to 500 d of supernate, and the concentrations of
C3a(desArg) and CSa(desArg) in the supernates were subsequently
measured by RIA (Amersham).
Effect of isolated C3a and C5a on neutrophil degranulation
Isolated neutrophils (1 x 106) suspended in HBSS/A were
incubated at 37°C with 15 jsg/ml of purified human C3a (gift of
Dr. T. Hugh, Scripps Clinic, La Jolla, California, USA) or with
500 nglml of recombinant human CSa (Sigma Chemical Co.) in
the presence or absence of 5 g/ml of cytochalasin B. Incuba-
tion of cells with HBSS/A or HBSS/A containing cytochalasin
B served as controls. For comparison, the same number of cells
were incubated with 375 l of NHP and 14 mg of cuprophan
fibers. The incubation volume was constant at 750 d. After two
hours, the supernates were assayed for elastase.
Effects of C3a and C5a in combination with heat-inactivated
plasma on neutrophil degranulation
The potential synergism between anaphylatoxins and plasma
noncomplement proteins in inducing neutrophil degranulation
was examined as follows. Isolated neutrophils (1 x 106) sus-
pended in HBSS/A were incubated at 37°C with a combination
of 15 pg/ml of purified C3a and 500 ng/ml of recombinant C5a in
the presence of 14 mg of cuprophan fibers and 375 pi of
heat-inactivated plasma (the heat treatment inactivates the
APC). Incubation of cells with cuprophan and heat-inactivated
plasma, or with cuprophan and NHP, or with HBSS/A alone
served as controls. The incubation volume was constant at 750
j.d. After two hours, the supernates were assayed for elastase.
Effect of IgG on cuprophan-induced neutrophil degranulation
Fc receptor-mediated phagocytosis of IgG coated particles by
neutrophils induces degranulation [21], and we have previously
demonstrated that, when incubated with plasma, cuprophan
membranes bind IgG [31]. The role of IgG in cuprophan-
induced neutrophil degranulation was therefore examined by
depletion of IgG from plasma.
Heparinized NHP from various normal donors was pooled.
An aliquot of the plasma was diluted to 75% with PBS and
frozen at —70°C prior to use. IgG-depleted plasma was prepared
by chromatographing a 12 ml aliquot of NHP from individual
donors on a 25 ml column of immobilized Protein G (Protein G
Sepharose 4 Fast Flow, Pharmacia-LKB). The chromato-
graphic fractions containing the breakthrough proteins were
combined and diluted with PBS such that the total protein
concentration (as determined by A280) was equal to 75% of that
of NHP. The residual IgG concentration in the pooled fractions
was less than 0.01 g/dl (the detection limit of the assay), as
determined by nephelometry using an N Immunoglobuhin kit
and the BN 100 Nephelometer (Behring Diagnostic Inc., Som-
erville, New Jersey, USA). The various IgG-depleted plasma
pools were combined.
To examine the effect of IgG on neutrophil degranulation in
the absence of complement activation, an aliquot of IgG-
depleted plasma was incubated at 56°C for 30 minutes prior to
use in the experiment described below. Neutrophils (1 x 106
cells suspended in 375 jd of HBSS/A) were incubated at 37°C
with 14 mg of cuprophan fibers and 375 d of one of the
following reagents: (i) NHP; (ii) IgG-depleted plasma; (iii)
IgG-depleted, heat-activated plasma; (iv) IgG-depleted plasma
supplemented with 3.375 mg of IgG (Miles, Inc., West Haven,
Connecticut, USA) (equivalent to plasma IgG concentration of
1.2 g/dl); or (v) HBSS/A. After two hours, the supernates were
assayed for elastase.
Cytofluorometic analysis of CDJ8 deficient neutrophils
The neutrophils from a patient with a congenital abnormality
in the expression of CD18 (the common 13 chain shared by the
132 integrins, CR3, LFA-1, and p 150,95) were utilized in the
study of cuprophan-induced neutrophil degranulation. Expres-
sion of CD18 was analyzed by cytofluorometry. Aliquots of 50
d of neutrophils (1 x 106 cells) from the patient or from a
normal donor were incubated at 37°C with 50 d of PBS
containing 50 g'ml of monoclonal anti-CD18 (60.3, Bristol-
Myers Squibb, Seattle, Washington, USA). After 30 minutes,
the cells were washed with RPMI, and incubated at 37°C with
50 pJ of FITC-conjugated anti-mouse IgG (Sigma Chemical Co.)
diluted 1:20 with PBS. After 30 minutes, the cells were washed
and analyzed using a Cytofiurograf uS (Ortho Diagnostics
Systems Inc., Westwood, Massachusetts, USA).
Requirement of 132 inte grins for cuprophan-induced
degranulation
To determine if the 132 integrin family of receptors is required
for cuprophan-induced neutrophil degranulation, 1 x 106 CD18-
deficient neutrophils or normal neutrophils (suspended in 375 .d
of HBSS/A) were incubated with 14 mg of cuprophan fibers and
375 .d of NHP. (To ensure that the differences in degranulation
between normal and abnormal cells were due to differences in
the properties of the cells and not to differences in the plasma
constituents, a pool of NHP from six normal individuals was
used in all these experiments). After incubation at 37°C for two
hours, the supernates were assayed for elastase. As a control,
neutrophils (2.5 x 106) from the patient or from volunteer
donors were incubated at 37°C with S g/ml of cytochalasin B.
After five minutes, 250 tl of PBS containing fMLP (1 m final
concentration, Sigma Chemical Co.) was added, (total volume
of the reaction mixture was 500 d) and the incubation was
continued for an additional 45 minutes. The supernate was
subsequently assayed for elastase.
6000
3000
Buffer NHP NI-P CuAP
300
Cheung et al: Hemodialysis-induced neutrophil degranulation 653
150
w
0.
Buffer Buffer
+Cu
Fig. 1. Direct effect of cuprophan membrane on neutrophil degranu-
lation in the absence of plasma. Incubation of neutrophils with buffer
(HBSS/A) alone (Li) induced a modest release of elastase from neutro-
phils. Addition of cuprophan fibers (Cu) to the buffer (U) increased the
release (N = 8, P < 0.05) by a very modest amount.
Statistical analyses
Values are reported as means SEM. Differences in concen-
trations of elastase between groups were analyzed by Student's
unpaired two-tailed t-test. P values < 0.05 were considered to
be statistically significant.
Results
Effect of cuprophan membrane on neutrophil degranulation
in the absence of plasma
Following incubation of neutrophils in HBSS/A, a relatively
modest amount of elastase was detected in the supernate (Fig.
1). When cuprophan fibers were included in the reaction mix-
ture, a very small increase in the release of elastase was
observed, although the difference was statistically significant (N
= 8; P < 0.05 vs. buffer alone).
Effect of plasma on neutrophil degranulation
The effect of plasma on degranulation was studied by incu-
bating neutrophils with plasma in the presence or absence of
cuprophan membrane. The addition of NHP to cells enhanced
the release of elastase significantly compared to incubation of
cells with buffer alone (N 12; P < 0.001; Fig. 2). When
ci)0)
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Fig. 2. Effect of plasma on neutrophil degranulation. Incubation of
neutrophils with normal human plasma (NHP, ) significantly en-
hanced the release of elastase compared to incubation with HBSS/A
(buffer) alone. Addition of cuprophan fibers (Cu) to NHP (•) in the
incubation further increased the release by fivefold (N = 12, P < 0.001).
Cells incubated with cuprophan activated plasma (CuAP, 2) degranu-
lated less than those incubated with NHP, suggesting that the degran-
ulating activity generated during exposure of plasma to cuprophan did
not reside in the fluid phase alone.
cuprophan membrane was added to cells and NHP, elastase
release increased by approximately fivefold compared to incu-
bation of cells with NHP without membrane (N = 12; P <
0.001). Compared to incubation of cells with cuprophan mem-
brane alone, the addition of NHP to cuprophan and cells
increased the release by —25-fold. These observations demon-
strate the importance of both plasma and cuprophan membrane
in the stimulation of neutrophil degranulation. In addition, these
results show that in the absence of plasma, the contribution of
the membrane to neutrophil degranulation is trivial. Similar
results were obtained when cuprophan flat sheets (gift of Dr.
Baurmeister and Dr. Vienken, Akzo, Wuppertal, Germany)
were substituted for cuprophan hollow fibers in the incubation
with neutrophils and NHP (data not shown).
The importance of plasma in cuprophan-induced degranula-
tion suggested the possibility that this process is mediated by
plasma components, such as complement C5a, that are acti-
vated by the cuprophan membrane and subsequently released
into the plasma. Therefore, the effect of cuprophan-activated
plasma was tested. After incubation with NHP, the cuprophan
fibers were discarded and neutrophils were incubated with the
cuprophan-activated plasma. Compared to NHP, cuprophan-
activated plasma induced less degranulation (N = 12; P < 0.05,
cuprophan-activated plasma vs. NHP) (Fig. 2). These results
indicate that C5a alone does not account for the degranulating
activity observed when neutrophils are incubated with plasma
and cuprophan. Further, these observations imply that mem-
brane-bound proteins contribute to the degranulation process.
Effect of heat inactivation or chelation of divalent cations on
neutrophil degranulation induced by plasma and cuprophan
Activation of the APC is dependent on both heat-sensitive
components and Mg In order to determine the contribution
of complement activation on hemodialysis membrane-induced
neutrophil degranulation, the effects of heat treatment of
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Fig. 3. Effect of heat inactivation or chelation of divalent cations on
neutrophil degranulation induced by plasma and cuprophan. Compared
to normal human plasma (NHP, •), heat-inactivated plasma (HIP, )
induced 57% less elastase release from neutrophils in the presence of
cuprophan (Cu) (N = 12;P <0.001). Chelation of both Ca and Mg
with EDTA (D) virtually abolished degranulation, whereas selective
chelation of Ca with EGTA (I) reduced the release by only 45% (N
= 8, P < 0.001). Treatment of HIP with EGTA (111111) significantly
reduced degranulation compared to either HIP without EGTA or NHP
chelated with EGTA, suggesting that the heat-stable plasma degranu-
lating activity is Ca + dependent.
plasma and chelation of divalent cations with EDTA or EGTA
were analyzed. EDTA chelates both Ca and Mg , whereas
EGTA chelates Ca1 ÷ but not Mg Thus, plasma treated with
Mg-EGTA will support activation of the APC, but heat-treated
plasma or plasma treated with EDTA will not.
Compared to NHP, incubation of neutrophils with cuprophan
in the presence of heat-inactivated plasma (HIP) decreased
elastase release by 57% (N = 12; P < 0.001; Fig. 3). These
results suggest that the majority of the degranulation process is
mediated by factors that are dependent on complement activa-
tion, however, a significant portion of the process does not
require complement activation. Selective chelation of Ca
with EGTA reduced the release of elastase by 45% (N = 8, P <
0.001; Fig. 3). These results are consistent with the concept that
over 50% of the degranulation process requires activation of the
APC, however, a significant element of the degranulation
process is dependent upon Ca Chelation of both Ca and
Mg with EDTA abolished degranulation (Fig. 3).
To determine whether the Ca + dependent component is
heat stable or heat sensitive, neutrophils were incubated with
cuprophan fibers and heat-inactivated plasma that had been
treated with EGTA. Elastase release under these conditions
was markedly diminished compared to incubation with heat-
inactivated plasma without EGTA (N = 12; P < 0.001) or
incubation with NHP with EGTA (N = 12; P < 0.001). These
data suggest that the heat stable (complement independent)
component requires Ca .
The requirement for extracellular divalent cations for neutro-
phil degranulation induced by another agonist was also exam-
ined. In contrast to stimulation by NHP and cuprophan, the
addition of EDTA enhanced degranulation induced by PMA
(3,787 877 ng/mI vs. 5,820 883 nglml; N 6; P > 0.05).
These results demonstrate that neutrophil degranulation can
occur in the absence of extracellular divalent cations, although
Fig. 4. Effect of complement depletion on plasma induced neutrophil
degranulation in the presence of cuprophan. A. C3 depletion. Neutro-
phils were incubated with cuprophan fibers (Cu) in the presence of
normal human plasma (NHP, •), C3 depleted plasma (C3DP, ), or
C3DP that had been repleted with purified C3 (LIII). Cells incubated with
HBSS/A (buffer) in the presence of cuprophan (D) served as control.
Depletion of C3 from plasma diminished elastase release by 62% (N =
18, P <0.001 vs. NHP). Repletion of C3DP with C3 restored the release
reaction completely (P> 0.05 vs. NHP). B. C5 depletion. Neutrophils
were incubated with Cu in the presence of NHP (•), CS depleted
plasma (C5DP, ), or CSDP that had been repleted with purified C5(Eli). Cells incubated with buffer in the presence of Cu () served as
control. Depletion of CS from plasma diminished elastase release by
26% (N = 29; P < 0.05 vs. NHP). Repletion of C5DP with CS restored
the release reaction completely (F> 0.05 vs. NHP).
some mechanisms have an absolute requirement for divalent
cations.
Effect of complement depletion on plasma-induced neutrophil
degranulation
Inasmuch as cuprophan membrane activates complement
[1—4, 23, 24] and activated complement fragments are known to
stimulate neutrophils [5, 6, 32, 33], the effect of complement on
cuprophan-induced neutrophil degranulation was studied by
using plasma depleted of C3 or CS. When C3 depleted plasma
was substituted for NHP, elastase release decreased by 62% (N
= 18; P < 0.001; Fig. 4A). Repleting the C3 depleted plasma
with purified C3 completely restored the capacity of the plasma
to induce neutrophil degranulation in the presence of cu-
prophan. The latter observation indicates that the affinity chro-
matographic procedure did not deplete substances other than
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C3 that were essential in inducing neutrophil degranulation.
Inasmuch as degranulation induced by repletion of C3-depleted
plasma with C3 did not exceed that induced by NHP (P> 0.05),
these data also suggest that the chromatographic procedure did
not enhance the capacity of the plasma to induce degranulation.
An additional control for the effect of the chromatographic
procedure was provided by subjecting human serum albumin to
the same preparatory procedure as that used for C3 depletion.
Incubation of neutrophils with albumin treated in this manner
resulted in only very modest degranulation (189 10 ng/ml; N
= 4). These values were not significantly different compared to
those obtained by incubating neutrophils with untreated serum
albumin (166 14 ng/ml; N = 4; P> 0.05).
Together, these data suggest that complement activation was
responsible for —60% of the degranulation when neutrophils
were exposed to cuprophan membrane and plasma simulta-
neously.
The effect of C3 depletion on neutrophil degranulation,
however, might be indirect since activation of C5 and genera-
tion of the membrane attack complex of complement (C5b-9)
would not occur in the absence of C3. Therefore, the effect of
CS depletion was also examined. Substitution of NHP with CS
depleted plasma during the incubation of neutrophils with
cuprophan decreased the release of elastase by 26% (N =29; P
< 0.05; Fig. 4B). Again, repletion of the CS depleted plasma
with purified CS completely restored the capacity of the plasma
to induce neutrophil degranulation. These data suggest that
products of CS activation or generation of the membrane attack
complex or both contributed to the degranulation process.
Effect ofC3a or C5a on neutrophil degranulation in the
absence of plasma
Previous studies have shown that C3a and CSa are generated
during clinical hemodialysis using cuprophan membrane [2, 3]
and that, under certain circumstances, these anaphylatoxins
can induce neutrophil degranulation in vitro [32, 33]. Accord-
ingly, experiments were designed to assess the contribution of
C3a and CSa to the degranulation.
First, the generation of these activation products under the
present experimental conditions was quantified. Incubation of
NHP in the presence of cuprophan generated 14,599 1,115
nglml of C3a(desArg) and 241 9 ng/ml of CSdesArg) in the
plasma (N = 4). Addition of neutrophils to the incubation did
not decrease the concentration of CSa in the fluid phase
significantly (217 12 nglml, N = 4, P > 0.05), demonstrating
that the amount of CSa that was bound to specific CSa receptors
on neutrophil surface (—1 to 3 x i0 receptors/cell [34]) was so
small compared to the total amount of CSa generated that it was
not reflected by changes in plasma levels.
To determine directly the effects of C3a on neutrophil degran-
ulation, cells were incubated with C3a alone, with cytochalasin
B alone, or with the combination of C3a and cytochalasin B.
Cytochalasin B has been used extensively in previous studies to
enhance secretory events by inflammatory cells [32, 33]. In the
absence of cytochalasin B, C3a (at 15 g/ml, a concentration
equivalent to that generated in plasma during incubation with
cuprophan) failed to stimulate the release of elastase from
neutrophils (N = 8; P> 0.05 vs. buffer; Fig. SA). Cytochalasin
B alone was also without effect (N = 8; P > 0.05 vs. buffer).
Fig. 5. Neutrophil degranulation induced by anaphylatoxins. A. C3a.
When neutrophils were incubated with either purified human C3a (15
pg/mI) (0) or cytochalasin B (CB, 11111), the amount of elastase released
was not different from that released when cells were incubated with
HBSS/A (buffer, ci). When neutrophils were incubated with cytocha-
lasin and C3a simultaneously (0), elastase release increased by 4x (N
= 8; P < 0.01 vs. buffer). The magnitude of release however, was
significantly less than that observed when cells were incubated with
NHP and cuprophan fibers (Cu, U). B. C5a. Similar to C3a, recombi-
nant human C5a (500 ng/ml, 0) was ineffective in inducing neutrophil
degranulation. When neutrophils were incubated with cytochalasin
(CB) and CSa (500 ng/ml) simultaneously (0), elastase release in-
creased by 21x (N = 7; P < 0.001 vs. buffer).
When neutrophils were presensitized with cytochalasin B, C3a
enhanced the release of elastase by fourfold (N = 8; P < 0.01
vs. buffer).
Similarly, CSa alone (at 500 ng/ml) failed to induce elastase
release (N = 7; P > 0.05 compared to buffer; Fig. 5B). When
cytochalasin B was added, however, C5a enhanced the release
of elastase by 21-fold (N = 7; P < 0.001 vs. buffer). The
magnitude of this release was, however, significantly lower than
that observed during incubation of neutrophils with NHP and
cuprophan simultaneously. These studies suggest that neither
C3a alone or CSa alone contributes significantly to the neutro-
phil degranulation induced by cuprophan membrane and NHP.
Synergistic effects of C3a and C5a with other plasma proteins
on neutrophil degranulation
Although neither C3a nor C5a alone induced neutrophil
degranulation, the possibility that these anaphylatoxins have a
synergistic effect with other plasma proteins was investigated.
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Fig. 6. Contribution of C3a and C5a to neutrophil degranulation in the
presence of heat-inactivated plasma. When C3a (15 tg/mI) and C5a
(500 nglml) were added simultaneously to heat inactivated plasma
(HIP), cuprophan membranes (Cu), and neutrophils (a), a statistically
significant increase in elastase release was observed compared to
incubation with HIP, Cu, and cells alone (0, N 8; P < 0.001). The
magnitude of degranulation, however, was substantially lower than that
observed when cells were incubated with normal plasma (NHP) and
cuprophan (U). These data suggest that the anaphylatoxins may play a
synergistic role with other noncomplement plasma proteins in the
degranulation process, but their contribution to total degranulation
induced by NHP and cuprophan is relatively small.
Heating plasma to 56°C x 30 minutes inactivates factor B so
that the APC is not activated by cuprophan membrane. When
C3a and C5a were added simultaneously to cells, heat-inacti-
vated plasma, and cuprophan membrane, there was a statistical
significant increase in elastase release compared to incubation
without the addition of anaphylatoxins (966 63 ng/ml vs. 617
40 ng/ml, N = 8, P < 0.001). This degree of degranulation,
however, was still far lower than that observed when cells were
incubated with cuprophan and NHP (Fig. 6). These data suggest
that anaphylatoxins may play a role in neutrophil degranulation
induced by cuprophan and plasma, but the contribution is
small. These results also indicate that plasma noncomplement
components participate in this process.
Effects of IgG depletion on neutrophil degranulation
Fcreceptor-mediated phagocytosis of IgG coated particles by
neutrophils induces degranulation [21], and we have previously
demonstrated that, when incubated with plasma, cuprophan
membranes bind IgG [31]. To determine if interactions between
membrane-bound IgG and neutrophil Fc receptors is required
for cuprophan-induced neutrophil degranulation, neutrophils
were incubated with cuprophan fibers in the presence of either
IgG-depleted plasma or NHP. There was no difference in
elastase release between these two groups (N = 12; P> 0.05;
Fig. 7). Repletion of IgG-depleted plasma with purified IgG did
not enhance degranulation (N 12; P > 0.05 vs. NHP or
IgG-depleted plasma). Quantitation of residual IgG in plasma
following the depletion process showed that <0.01 g/dl re-
mained. To insure that the residual IgG was not sufficient to
induce degranulation, neutrophils were incubated with cu-
prophan membrane and either buffer or buffer containing 0.01
g/dl of purified IgG. The presence of this amount of IgG in the
buffer did not stimulate degranulation (154 28 ng/ml for IgG
vs. 134 24 nglml for buffer; N = 8; P > 0.05).
HP HIIgGDP Buffer
+Cu +Cu
Fig. 7. Effect ofIgG depletion on plasma induced neutrophil degran-
ulation in the presence of cuprophan. When neutrophils were incubated
with IgG depleted plasma (IgGDP) in the presence of cuprophan (Cu),
the amount of elastase released was similar to that observed with
normal human plasma (NHP) (N = 12; P> 0.05). Repletion of IgGDP
with purified lgG did not enhance degranulation. Inactivating comple-
ment by heat treatment of plasma (heat inactivated plasma, HIP)
decreased degranulation by —60% (N = 12; P < 0.001 vs. NHP). Heat
treatment of IgG-depleted plasma (HIIgGDP) produced similar results(N = 12; P > 0.05 vs. HIP). These data suggest that IgG does not
participate significantly in cuprophan-induced neutrophil degranulation
in the presence or absence of complement activation.
The effect of IgG on neutrophils could be obscured by the
stimulatory effect of activated complement. To test this hypoth-
esis, complement activity was abolished by heat treatment of
plasma, and the effect of IgG depletion was examined. Heat-
treated, IgG-depleted plasma induced a similar degree of de-
granulation in the presence of cuprophan compared to heat-
treated plasma without IgG depletion (N = 12; F> 0.05; Fig. 7).
These results indicate that interactions between IgG and Fc
receptors are not essential for degranulation induced by cu-
prophan and plasma.
Effect of /32 inte grins on degranulation
Our previous studies [31] have demonstrated that neutrophil
binding to cuprophan plate membranes that have been incu-
bated with plasma is mediated through interactions between
CR3 (CD1 lb/CD 18) on the neutrophils and its counterligand,
iC3b, that is present on the membranes as a result of activation
of the APC. To determine if neutrophil degranulation is also
dependent upon CR3, neutrophils were treated with a mono-
clonal antibody (60.1, a gift from Dr. P. Beatty, University of
Utah) that recognizes an epitope expressed by CD! lb (the a
chain of CR3) [35], or with a monoclonal antibody (60.3,
Bristol-Myers Squibb) that recognizes an epitope expressed by
CDI 8 (the /3 chain of CR3, LFA- 1, and p150,95). The antibody
60.1 has been shown to inhibit neutrophil binding to cuprophan
plate membranes in the presence of plasma [31]. Neither
antibody 60.1 (at concentrations up to 200 g/ml) nor 60.3 (at
concentrations up to 25 p.g/ml) inhibited neutrophil degranula-
tion (not shown). There appeared to be two plausible explana-
tions for these observations. First, the degranulation process
might not be dependent upon CR3 (or other /32 integrins).
Second, the degranulation process might be dependent upon
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Fig. 8. Cytofluorometric analysis of CDI8 on neutrophils. Isolated
neutrophils were incubated with monoclonal anti-CDI8 as primary
antibody and FITC-conjugated anti-mouse IgG as secondary antibody
and subjected to FACS analysis. Expression of CDI8 was prominent on
normal neutrophils (A) but was absent on neutrophils from the patient
with congenital deficiency in CD18 expression (B).
ligand binding to CR3 (or other 132 integrins), but the mono-
clonal antibodies might not block the receptor-ligand interac-
tions. To distinguish between these two possibilities, the de-
granulating properties of the neutrophuls from a patient with
leukocyte adhesion deficiency syndrome were studied. The
neutrophils from this patient did not express CD18 (Fig. 8).
When CD18-deficient neutrophils were incubated with Cu-
prophan and NHP, the release of elastase was only 11% of that
observed when normal cells were studied under the identical
conditions (N = 10 for CD18-deficient cells and N = 18 for
normal cells; P < 0.001; Fig. 9A). In contrast, the CD18-
deficient cells degranulated normally in response to stimulation
with fMLP (N = 9 for CD18-deficient cells and N = 18 for
Fig. 9. Comparison of degranulation by normal and CDI8-deficient
neutrophils. A. Stimulation with cuprophan membranes (Cu) and NHP.
Incubation of normal neutrophils () with NHP and Cu induced nine
times more elastase release compared to incubation with CD18-defi-
cient cells (0) (N = 18 for normal cells and N = 10 for CD18-deficient
cells; P < 0.001). B. Stimulation with fMLP. Stimulation of normal (•)
and CD18-deficient cells (0) with fMLP induced a similar degree of
degranulation (N = 18 for normal cells and N = 9 for CD18-deficient
cells; P > 0.05). Together, these results indicate that the defect in
cuprophan induced degranulation is a consequence of the CD18 defi-
ciency since the neutrophils from the patient with leukocyte adhesion
deficiency degranulate normally in response to fMLP.
normal cells; P > 0.05; Fig. 9B). These data show that the
defect in elastase release by the abnormal cells in response to
incubation with plasma and cuprophan fibers is specific for
CD 18-dependent mechanisms and that cuprophan-induced neu-
trophil degranulation requires one or more members of the
132-integrin family of receptors.
Discussion
The studies reported here have shown that ligation of /32
integrins is an essential component of the process by which
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neutrophils are induced to degranulate when exposed to cu-
prophan membrane in the presence of plasma. Further, our
studies suggest that both complement-dependent and comple-
ment-independent factors participate as counterligands in this
process.
Exposure of neutrophils to cuprophan fibers in the absence of
plasma stimulated elastase release (Fig. 1). The effect of cellu-
losic membranes on leukocyte activation in the absence of
plasma has also been the subject of previous investigations by
others. For example, cellulosic membranes have been reported
to stimulate both monocytes to release interleukin-l and PGE2
[36, 37] and neutrophils to release oxygen radicals [37]. The
effect of cuprophan membrane on neutrophil degranulation in
the absence of plasma proteins, however, appears to be very
modest (Fig. 1). Addition of plasma to the mixture caused a
dramatic increase in degranulation (Fig. 2), demonstrating that
both the dialysis membrane and plasma are essential compo-
nents of the degranulation process.
Two lines of evidence indicate that complement activation is
required for maximal degranulation. First, neutrophil degranu-
lation was reduced by 57% (Fig. 3) when complement was
inactivated by heating the plasma. Second, degranulation was
reduced by 62% when plasma was depleted of C3 (Fig. 4A). A
potential mechanism by which complement activation partici-
pates in the degranulation process is by providing a ligand
through which neutrophils can adhere to the dialysis mem-
brane. Incubation of plasma with cuprophan membrane results
in activation of the APC [30, 31]. As a consequence, C3b binds
to the membrane and is subsequently converted to iC3b [311 by
the concert actions of factor H and factor I. iC3b is the ligand
for CR3, a /32 integrin that is expressed constitutively by
neutrophils [6]. Our previous studies have shown that neutro-
phil adherence to cuprophan membranes is mediated through
the interactions of iC3b and CR3 [31].
While both C3a and CSa are generated as consequence of
cuprophan induced activation of the APC, two lines of evidence
indicate that degranulation is not primarily mediated by these
peptides alone. First, cuprophan activated plasma (that con-
tained both C3a and C5a) induced less degranulation than
plasma that has not been incubated with cuprophan (Fig. 2). It
should be noted, however, that the C3a and C5a that had been
generated during the incubation of NHP with cuprophan were
likely to have undergone degradation into C3adesArg and
CSadesArg by the time the neutrophils were exposed to these
peptides, thus potentially diminishing their potency in stimulat-
ing the cells. Second, neither C3a nor CSa alone (when used at
concentrations that were equivalent to or higher than those
generated during incubation of plasma with cuprophan mem-
brane) induced degranulation in the absence of cytochalasin B
(Fig. 5). Additional studies, however, suggest that C3a and C5a
may have a limited synergistic role in inducing neutrophil
degranulation in the presence of heat-inactivated plasma and
cuprophan membrane (Fig. 6). The mechanisms that accounts
for this augmentation has not been identified, but conceivably
the up-regulation of CR3 expression by the anaphylatoxins may
contribute to the process.
Depletion of CS reduces the degranulating capacity of plasma
by approximately 25% (Fig. 4B). In addition to the generation of
C5a, CS may contribute to the degranulation process by partic-
ipating in the formation of the membrane attack complex
(C5b-9). While the primary function of the membrane attack
complex is to induce cytolysis, compelling evidence indicates
that sublytic amounts of C5b-9 induce biological responses in
neutrophils [38]. Deppisch and colleagues have reported that
during hemodialysis using cuprophan membrane, membrane
attack complexes are deposited on neutrophils [4]. Whether
C5b-9 complexes participate in the process of neutrophil de-
granulation induced by dialysis membranes, however, remains
to be determined.
When plasma complement activity is eliminated by either
heat inactivation or depletion of C3, approximately 40% of the
degranulating activity remains. These results indicate that cu-
prophan membrane-associated neutrophil degranulation can be
induced by heat stable constituents of plasma that are not
dependent on complement activation. Our previous studies
have demonstrated that during incubation with plasma, cu-
prophan membrane binds IgG [31], and neutrophils constitu-
tively express receptors for the Fc fragment of IgG [6]. Fur-
thermore, phagocytosis of particles opsonized with IgG induces
neutrophil degranulation [6]. Accordingly, it seemed possible
that the noncomplement, heat stable plasma component in-
volved in the degranulation process was IgG. The results of our
experiments, however, demonstrate that interactions between
membrane associated IgG and neutrophil Fc receptors do not
mediate cuprophan induced degranulation (Fig. 7).
Degranulation is abolished when divalent cations are chelated
with EDTA (Fig. 3). Divalent cations can participate in the
degranulation process in three ways. First, activation of the
APC is Mg + dependent [39]. Second, binding of CR3 to its
counterligands is divalent cation dependent [40]. Third, extra-
cellular cations may be involved in the signalling mechanism
that induces degranulation (such as, in response to fMLP) [41].
In our present studies, selective chelation of extracellular Ca +
(with EGTA) reduces degranulation by 45%. Under these
conditions, activation of the APC can still occur because this
process requires Mg but not Ca . These results imply that
the complement independent component of dialysis membrane
induced degranulation is, in large part, Ca dependent. Addi-
tional support for this conclusion was provided by experiments
which demonstrated that selective chelation of Ca + almost
completely abolished the degranulating activity of heat inacti-
vated (that is, complement inactivated) plasma (Fig. 3).
Stimulation of neutrophils with three different endotoxins (E.
coli 0SS:BS, E. co/i 011:B4, and S. minnesota at S gIml)
produced minimal effect. Pilot studies using flotation ultracen-
trifugation further indicated that virtually all of the plasma
degranulating activity is associated with nonlipid bearing pro-
teins. Together, these results indicate that neither endotoxin
nor plasma lipids contribute significantly to the degranulation
process.
When incubated with plasma and cuprophan membrane,
neutrophils from a patient with a congenital abnormality in
expression of CDI8 (Fig. 8) released 90% less elastase than
normal granulocytes (Fig. 9A). This defect in degranulation
appears to be specific for CD18-dependent mechanisms since
the abnormal cells released elastase normally in response to
fMLP (Fig. 9B). CD18 is the /3 chain shared by the three
members of the /32 integrin family of receptors; LFA-l (CD1 la!
CD18), CR3 (CD11b/CD18), and p150,95 (CDllc/CD18). CR3,
however, is the predominant f2 integrin that is present on the
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neutrophil surface [6]. That heat inactivation of plasma com-
plement or immunochemical depletion of C3 reduces elastase
release substantially (approximately 60%) suggests that inter-
actions between CR3 and iC3b are an important component of
the degranulation process.
Degranulation does occur, however, in the absence of com-
plement activation. That observation suggests that CR3 also
interacts with noncomplement plasma factors. The identity of
these complement independent ligands remains to be eluci-
dated. Studies by others have shown that fibrinogen [42],
fibronectin [43], serum amyloid P component [43] and coagula-
tion factor X [44] bind to CR3, but whether these proteins
contribute to hemodialysis associated degranulation remains to
be determined.
The mechanism that induces the degranulation process has
not been precisely identified. Conceivably, ligation of CR3 by
C3-related peptides and noncomplement plasma proteins di-
rectly transduces the signal that mediates degranulation. Alter-
natively, CR3 mediated adhesion may be necessary but not
sufficient for degranulation to occur. According to this concept,
adhesion of the neutrophils to the membrane is mediated by
CR3, but the signal for degranulation is induced through inter-
actions between another neutrophil receptor and its counterli-
gand. Further studies are required to distinguish between these
possibilities.
Ward and colleagues have presented evidence implicating
complement activation in the degranulation process during
hemodialysis in an ex vivo model [45]. They found that single
passage of whole blood through cuprophan membrane elicited
activation of C3 and degranulation of neutrophils. Plasma
C3a(desArg) level correlated with the release of neutrophil elas-
tase, although the magnitude of response of the neutrophils
varied widely among the blood donors. On the other hand, the
studies of Horl, Heidland, and colleagues have suggested that
the degranulation process is not necessarily complement depen-
dent [13—16]. Our results are consistent with the hypothesis that
both complement dependent and complement independent
mechanisms participate in the induction of degranulation. Thus,
the data reported herein appear to reconcile the apparent
discrepancies between the studies of the two groups cited
above. Dialysis membranes that have a high avidity for the
noncomplement factors may be expected to induce significant
neutrophil degranulation even if they lack the capacity to
activate complement.
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Appendix. Abbreviations
APC Alternative pathway of complement
BSA Bovine serum albumin
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